[Isoenzymes of creatine kinase in extracardiac disease and after various diagnostic and therapeutic procedures].
Creatine kinase MB isoenzyme was measured (using antibody inhibition) in serum of patients with exogenous intoxication, acute pancreatitis, cerebrovascular accidents, meningitis, encephalitis, skeletal muscle disease, shock, postoperative states and after coronary arteriography, cardiac catherisation of cardioversion. CK-MB activity was revealed only in sera of patients with exogenous intoxication (severity III and IV), polymyositis, scleroderma, after operation or after coronary arteriography, cardiac catherisation or cardioversion. As it is not possible to differentiate between CK-MB and CK-BB using inhibiting antibodies against CK-M subunit, CK-isoenzyme activity was determined in parallel, using precipitating antibodies. No CK-BB was found in any case. The determination of CK-MB isoenzyme after blocking of the CK-MB subunit by means of inhibiting antibodies is suitable  for clinical diagnosis. The method significantly increases the value of creatine kinase measurement.
D000792:Angiography; D006328:Cardiac Catheterization; D002543:Cerebral Hemorrhage / Q000201:enzymology; D017023:Coronary Angiography; D003402:Creatine Kinase / Q000097:blood*; D004554:Electric Countershock; D004660:Encephalitis / Q000201:enzymology; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008581:Meningitis / Q000201:enzymology; D009135:Muscular Diseases / Q000201:enzymology; D009220:Myositis / Q000201:enzymology; D010195:Pancreatitis / Q000201:enzymology; D011041:Poisoning / Q000201:enzymology; D012595:Scleroderma, Systemic / Q000201:enzymology; D012769:Shock / Q000201:enzymology
D007527:Isoenzymes; D003402:Creatine Kinase
Isoenzyme der Kreatinkinase bei extrakardialen Erkrankungen und nach diagnostischen und therapeutischen Eingriffen